Search Results - "Emsley, Robin"

Refine Results
  1. 1
  2. 2

    Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings? by Emsley, Robin

    Published in Therapeutic Advances in Psychopharmacology (01-01-2023)
    “…Progressive structural brain changes are well documented in schizophrenia and have been linked to both illness progression and the extent of antipsychotic…”
    Get full text
    Book Review Journal Article
  3. 3

    DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions by Ovenden, Ellen S., McGregor, Nathaniel W., Emsley, Robin A., Warnich, Louise

    “…Antipsychotic response in schizophrenia is a complex, multifactorial trait influenced by pharmacogenetic factors. With genetic studies thus far providing…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder by O'Connell, Kevin S., McGregor, Nathaniel W., Lochner, Christine, Emsley, Robin, Warnich, Louise

    Published in Molecular and cellular neuroscience (01-04-2018)
    “…Considerable evidence suggests that autism spectrum disorders (ASD), schizophrenia (SCZ), bipolar disorder (BD) and obsessive-compulsive disorder (OCD) share a…”
    Get full text
    Journal Article
  6. 6

    Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates by Emsley, Robin, Rabinowitz, Jonathan, Medori, Rossella

    Published in Schizophrenia research (01-01-2007)
    “…Abstract Background Recently, the “Remission in Schizophrenia Working Group” proposed remission criteria consisting of a reduction to mild levels on key…”
    Get full text
    Journal Article
  7. 7

    A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia by Malan-Müller, Stefanie, Kilian, Sanja, van den Heuvel, Leigh L, Bardien, Soraya, Asmal, Laila, Warnich, Louise, Emsley, Robin A, Hemmings, Sîan M.J, Seedat, Soraya

    Published in Schizophrenia research (01-01-2016)
    “…Abstract Metabolic syndrome (MetS) is a cluster of factors that increases the risk of cardiovascular disease (CVD), one of the leading causes of mortality in…”
    Get full text
    Journal Article
  8. 8

    Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia by Emsley, Robin, Rabinowitz, Jonathan, Medori, Rossella

    Published in The American journal of psychiatry (01-04-2006)
    “…Objective: The authors examined early onset of antipsychotic action and early prediction of nonresponse to antipsychotics in patients with first-episode…”
    Get full text
    Journal Article
  9. 9

    Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study by Davidson, Michael, Emsley, Robin, Kramer, Michelle, Ford, Lisa, Pan, Guohua, Lim, Pilar, Eerdekens, Mariëlle

    Published in Schizophrenia research (01-07-2007)
    “…Abstract Background Paliperidone extended-release tablet (paliperidone ER) is an oral psychotropic agent developed for schizophrenia treatment. Paliperidone…”
    Get full text
    Journal Article
  10. 10

    Rate and predictors of non‐response to first‐line antipsychotic treatment in first‐episode schizophrenia by Chiliza, Bonginkosi, Asmal, Laila, Kilian, Sanja, Phahladira, Lebogang, Emsley, Robin

    Published in Human psychopharmacology (01-05-2015)
    “…Objective The goals of this study were to (i) estimate the rate of non‐response to first‐line treatment in first‐episode schizophrenia, (ii) evaluate other…”
    Get full text
    Journal Article
  11. 11

    Comparison of Treatment Response in Second-Episode Versus First-Episode Schizophrenia by EMSLEY, Robin, OOSTHUIZEN, Petrus, KOEN, Liezl, NIEHAUS, Dana, MARTINEZ, Lupe

    Published in Journal of clinical psychopharmacology (01-02-2013)
    “…This study investigated whether illness progression and treatment refractoriness emerge after relapse in schizophrenia. We compared outcomes in a cohort…”
    Get full text
    Journal Article
  12. 12

    Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophrenia by Schoemaker, Joep H., Vingerhoets, Ad J.J.M., Emsley, Robin A.

    Published in CNS spectrums (01-08-2019)
    “…IntroductionDespite consistently high discontinuation rates due to withdrawal of consent (WOC) and insufficient therapeutic effect (ITE) in schizophrenia…”
    Get full text
    Journal Article
  13. 13

    The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis by Emsley, Robin, Rabinowitz, Jonathan, Torreman, Martijn

    Published in Schizophrenia research (01-05-2003)
    “…The Positive and Negative Syndrome Scale (PANSS) is a widely used instrument for measuring severe psychopathology in adult patients with schizophrenia. Data,…”
    Get full text
    Journal Article
  14. 14

    Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration by Möller, Marisa, Du Preez, Jan L, Emsley, Robin, Harvey, Brian H

    Published in European neuropsychopharmacology (01-06-2011)
    “…Abstract Social isolation rearing (SIR) in rats induces behavioral and glutamatergic changes akin to schizophrenia. We studied the effects of 8 weeks SIR on…”
    Get full text
    Journal Article
  15. 15

    Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified? by Emsley, Robin, Fleischhacker, Wolfgang W

    Published in Schizophrenia research (01-11-2013)
    “…Abstract Background Placebo-controlled randomised controlled trials (RCTs) continue to be required or recommended by regulatory authorities for the licensing…”
    Get full text
    Journal Article
  16. 16

    Causal attributions, pathway to care and clinical features of first-episode psychosis: A South African perspective by Burns, Jonathan K., Jhazbhay, Khatija, Emsley, Robin A.

    Published in International journal of social psychiatry (01-09-2011)
    “…Background: Causal belief systems and help-seeking practices may impact on pathway to care and features of first-episode psychosis (FEP) that have prognostic…”
    Get full text
    Journal Article
  17. 17

    The concepts of remission and recovery in schizophrenia by Emsley, Robin, Chiliza, Bonginkosi, Asmal, Laila, Lehloenya, Keneilwa

    Published in Current opinion in psychiatry (01-03-2011)
    “…PURPOSE OF REVIEWUntil recently outcome studies in schizophrenia lacked standardized measures, and outcome expectations were generally pessimistic. The…”
    Get full text
    Journal Article
  18. 18

    Cognitive insight is associated with perceived body weight in overweight and obese adults by Suliman, Sharain, L van den Heuvel, Leigh, Kilian, Sanja, Bröcker, Erine, Asmal, Laila, Emsley, Robin, Seedat, Soraya

    Published in BMC public health (19-03-2021)
    “…Accurate perception of body weight is necessary for individuals with a high body mass index (BMI) to initiate strategies to improve their health status…”
    Get full text
    Journal Article
  19. 19

    Instruments measuring blunted affect in schizophrenia: a systematic review by Kilian, Sanja, Asmal, Laila, Goosen, Anneke, Chiliza, Bonginkosi, Phahladira, Lebogang, Emsley, Robin

    Published in PloS one (02-06-2015)
    “…Blunted affect, also referred to as emotional blunting, is a prominent symptom of schizophrenia. Patients with blunted affect have difficulty in expressing…”
    Get full text
    Journal Article
  20. 20

    Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial by Schooler, Nina, Rabinowitz, Jonathan, Davidson, Michael, Emsley, Robin, Harvey, Philip D., Kopala, Lili, McGorry, Patrick D., Van Hove, Ilse, Eerdekens, Marielle, Swyzen, Wim, De Smedt, Goedele

    Published in The American journal of psychiatry (01-05-2005)
    “…OBJECTIVE: The first episode of psychotic illness is a key intervention point. The initial experience with medication can affect willingness to accept…”
    Get full text
    Journal Article